Division of Gastroenterology, Department of Internal Medicine, Research Institute and Hospital, National Cancer Center, Goyang, Korea.
Division of Gastroenterology, Department of Internal Medicine, Chung-Ang University Hospital, Seoul, Korea.
Int J Colorectal Dis. 2023 Jun 10;38(1):167. doi: 10.1007/s00384-023-04448-z.
Endoscopic resection (ER) is a reliable treatment for early colorectal cancer without lymph node metastasis. We aimed to examine the effects of ER performed prior to T1 colorectal cancer (T1 CRC) surgery by comparing long-term survival after radical surgery with prior ER to that after radical surgery alone.
This retrospective study included patients who underwent surgical resection of T1 CRC at the National Cancer Center, Korea, between 2003 and 2017. All eligible patients (n = 543) were divided into primary and secondary surgery groups. To ensure similar characteristics between the groups, 1:1 propensity score matching was used. Baseline characteristics, gross and histological features, along with postoperative recurrence-free survival (RFS) between the two groups were compared. Cox proportional hazard model was used to identify the risk factors affecting recurrence after surgery. Cost analysis was performed to examine the cost-effectiveness of ER and radical surgeries.
No significant differences were observed in 5-year RFS between the two groups in matched data (96.9% vs. 95.5%, p = 0.596) and in the unadjusted model (97.2% vs. 96.8%, p = 0.930). This difference was also similar in subgroup analyses based on node status and high-risk histologic features. ER before surgery did not increase the medical costs of radical surgery.
ER prior to radical surgery did not affect the long-term oncologic outcomes of T1 CRC or significantly increased the medical costs. Attempting ER first for suspected T1 CRC would be a good strategy to avoid unnecessary surgery without concerns of worsening cancer-related prognosis.
内镜下切除术(ER)是治疗无淋巴结转移的早期结直肠癌的可靠方法。我们旨在通过比较 T1 结直肠癌(T1 CRC)术前 ER 与单纯根治性手术后的长期生存情况,来检验 T1 CRC 术前 ER 的效果。
本回顾性研究纳入了 2003 年至 2017 年在韩国国家癌症中心接受 T1 CRC 手术切除的患者。所有符合条件的患者(n=543)分为原发手术组和继发手术组。为了确保两组之间具有相似的特征,采用 1:1 倾向评分匹配。比较两组的基线特征、大体和组织学特征以及术后无复发生存(RFS)。采用 Cox 比例风险模型确定影响手术后复发的危险因素。进行成本分析以检验 ER 和根治性手术的成本效益。
在匹配数据中,两组的 5 年 RFS 无显著差异(96.9% vs. 95.5%,p=0.596),在未调整模型中也无显著差异(97.2% vs. 96.8%,p=0.930)。基于淋巴结状态和高危组织学特征的亚组分析也得到了类似的结果。手术前 ER 并未增加根治性手术的医疗费用。
T1 CRC 根治性手术前 ER 并不会影响长期肿瘤学结果,也不会显著增加医疗费用。对于疑似 T1 CRC 患者,首先尝试 ER 可能是一种避免不必要手术且不会恶化癌症相关预后的良好策略。